Understanding the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals in an enriched population being assessed for or entering substance use disorder…
Active Awarded Last action
- Contract number
- 75F40122F19002
- Awardee
-
Integrated Behavioral Health, Inc. UEI L9YZF5SG6WN1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,046,569
Award facts
- Contract value 100% obligated
- $1,046,568.62 Current and potential, with all options
- Completion date 82% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $219,949 | |
| Exercise an Option | $175,120 | |
| Exercise an Option | $165,966 | |
| Other Administrative Action | $0 | |
| Original award | $485,534 |
About this award
The Food and Drug Administration (FDA) awarded a $1.05M firm-fixed-price delivery order to Integrated Behavioral Health, Inc. to conduct research understanding the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among populations being assessed for or entering substance use disorder treatment. The work will be performed in Silver Spring, Maryland, with an ultimate completion date of September 28, 2027. This delivery order was awarded without a set-aside designation on September 16, 2022.
Integrated Behavioral Health, Inc. is a for-profit corporation specializing in behavioral health services and drug use surveillance to support public health monitoring. The company brings relevant expertise through prior federal awards, including a $3M CDC purchase order for the National Violent Death Reporting System and other FDA delivery orders focused on pharmaceutical misuse and emerging drug trends. Under this engagement, the contractor will leverage its behavioral health expertise to generate evidence regarding falsified pharmaceutical prevalence in substance use disorder populations, contributing to the FDA's efforts to combat pharmaceutical fraud and protect vulnerable populations seeking treatment.
Description
Understanding the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals in an enriched population being assessed for or entering substance use disorder treatment
Quick answers
Who was awarded contract 75F40122F19002?
75F40122F19002 was awarded to Integrated Behavioral Health, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 16, 2022.
How much is contract 75F40122F19002 worth?
The government has obligated $1,046,569 on 75F40122F19002.
Is contract 75F40122F19002 an order under another contract?
Yes. 75F40122F19002 is a delivery order under 75F40121D00032, an indefinite delivery contract.
Was contract 75F40122F19002 competed?
The extent of competition for 75F40122F19002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award